Document is current
Any future updates will be listed below
-
Authors
Andersson, Emelie https://orcid.org/0000-0002-4229-7629
Axelsson, Ulrika https://orcid.org/0000-0002-3712-4897
Rönnow, Carl-Fredrik https://orcid.org/0000-0001-5848-1407
Thorlacius, Henrik https://orcid.org/0000-0001-7827-996X
Persson, Linda
Fridhammar, Adam https://orcid.org/0000-0003-3715-003X
-
Funding
Funding for this research was provided by:
VINNOVA (2023-01621)
- License Information
-
More Information
Article History
Accepted: 23 March 2025
First Online: 21 April 2025
Declarations
:
: This work was supported by VINNOVA (Diary number 2023-01621). The funder played no role in the identification, design, conduct, and reporting of the analysis.
: UA and LP are employees of NanoEcho. UA and LP own shares in NanoEcho. CFR and HT are consultants to NanoEcho. EA and AF are employees of the Swedish Institute for Health Economics, which provides consulting services for governmental bodies, academic institutions, and commercial life science enterprises. The authors report no other conflict of interests in this work.
: Not applicable.
: Not applicable.
: All authors have read and approved the final manuscript for publication.
: The model is not made publicly available.
: Not applicable.
: All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Adam Fridhammar, Emelie Andersson and Linda Persson. The first draft of the manuscript was written by Adam Fridhammar, Emelie Andersson and Ulrika Axelsson, and all authors commented on previous versions of the manuscript. All authors have read and approved the final manuscript.
